WP-1193

N/A

Report date: 2024/05/24 09:41:22

NME

Base Information

Drug NameWP-1193

Drug Alias NameWP-1193WP 1193WP1193

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitorsMyc proto-oncogene protein inhibitorsHypoxia-inducible factor 1 alpha inhibitors +[4]

TargetsSignal transducer and activator of transcription 3Myc proto-oncogene proteinHypoxia-inducible factor 1 alpha

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMoleculin Biotech Inc

China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer Center

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A